Corcept Therapeutics Incorporated - Common Stock (CORT) stock analysis

CORT · Corcept Therapeutics Incorporated - Common Stock

Latest recorded price: USD 69.22

Model-estimated fair value: USD 19.41. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Biotechnology

At $69.22, CORT trades 256.7% above the model's base-case value of $19.41. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $15.44 in the conservative case and $24.18 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 23.7%, free cash flow margin 18.6%, ROIC 12.8%. The model flags 1 risk signal for this company.

Similar companies in Healthcare